AIMVION A/S
AimVion is a privately held research and development company focused on peptide based drugs for inflammatory and autoimmune diseases. The company was founded in 2015 based on its proprietary technology for a new class of anti-inflammatory peptides derived from human genetic elements. AimVion brings a team of experienced scientists, researchers and business man together to fulfill the need for better, safer and cheaper anti-inflammatory drugs of the future. The company has quickly established a portfolio of anti-inflammatory peptides in pre-clinical development stage and has focus on Rheumatoid Arthritis and Multiple Sclerosis as its primary indications.
AIMVION A/S
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2015-01-01
Address:
Aarhus, Midtjylland, Denmark
Country:
Denmark
Website Url:
http://www.aimvion.com
Total Employee:
11+
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS ASP.NET JQuery CDN
Similar Organizations
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Talisman Therapeutics
Talisman Tx is a stem cell research and development company committed to revolutionising the discovery of treatments for Alzheimer's disease
TPP Global Development
TPP Global Development is a preclinical stage drug development company focused on nervous system disorders, immunology, and oncology.
Official Site Inspections
http://www.aimvion.com
- Host name: a67c48129651a0940.awsglobalaccelerator.com
- IP address: 76.223.67.189
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
